![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](ci6552contents.gif)
Acta Cryst. (2005). E61, o1147-o1149 [ doi:10.1107/S1600536805009177 ]
-D-erythro-pentofuranosyl)-1H-benzimidazol-2(3H)-oneAbstract: The title nucleoside, C13H16N2O5, was prepared and characterized by X-ray crystallographic techniques. The crystal structure determination reveals that the furanose ring adopts a C2'-endo conformation, while the orientation of the benzimidazole moiety with respect to the sugar moiety is mid-anti. The crystal structure is stabilized by intermolecular O-H
O and N-H
O hydrogen bonds.
Online 31 March 2005
Copyright © International Union of Crystallography
IUCr Webmaster